Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF von Curtain, James P, Docherty, Kieran F, Jhund, Pardeep S, Petrie, Mark C, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Bengtsson, Olof, Langkilde, Anna Maria, Sjöstrand, Mikaela, Solomon, Scott D, McMurray, John J V

Volltext

Predictors of sudden cardiac death in high‐risk patients following a myocardial infarction von Docherty, Kieran F., Ferreira, João Pedro, Sharma, Abhinav, Girerd, Nicolas, Gregson, John, Duarte, Kevin, Petrie, Mark C., Jhund, Pardeep S., Dickstein, Kenneth, Pfeffer, Marc A., Pitt, Bertram, Rossignol, Patrick, Zannad, Faiez, McMurray, John J.V.

Volltext

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction von Dewan, Pooja, Docherty, Kieran F, McMurray, John J V

Volltext

Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis von Lee, Matthew M Y, Docherty, Kieran F, Sattar, Naveed, Mehta, Neil, Kalra, Ankur, Nowacki, Amy S, Solomon, Scott D, Vaduganathan, Muthiah, Petrie, Mark C, Jhund, Pardeep S, McMurray, John J V

Volltext

Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction von Docherty, Kieran F., McMurray, John J.V., Kalra, Paul R., Cleland, John G.F., Lang, Ninian N., Petrie, Mark C., Robertson, Michele, Ford, Ian

Volltext

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials von Vaduganathan, Muthiah, Docherty, Kieran F, Claggett, Brian L, Jhund, Pardeep S, de Boer, Rudolf A, Hernandez, Adrian F, Inzucchi, Silvio E, Kosiborod, Mikhail N, Lam, Carolyn S P, Martinez, Felipe, Shah, Sanjiv J, Desai, Akshay S, McMurray, John J V, Solomon, Scott D

Volltext

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials von Kristensen, Søren L, Rørth, Rasmus, Jhund, Pardeep S, Docherty, Kieran F, Sattar, Naveed, Preiss, David, Køber, Lars, Petrie, Mark C, McMurray, John J V

Volltext

SGLT2 Inhibitors and Iron: More Than Meets the Eye von Docherty, Kieran F

Volltext

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF von McEwan, Phil, Darlington, Oliver, McMurray, John J.V., Jhund, Pardeep S., Docherty, Kieran F., Böhm, Michael, Petrie, Mark C., Bergenheim, Klas, Qin, Lei

Volltext

Heart failure medical therapy in the last years of life: Prognosis and practicalities von Doherty, Daniel J., Abdin, Amr, Docherty, Kieran F.

Volltext

A welcome 'failure' of gliflozins: blood pressure reduction in heart failure von Docherty, Kieran F, Jhund, Pardeep S

Volltext

Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance? von Campbell, Ross T, Docherty, Kieran F

Volltext

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial von Kosiborod, Mikhail N., Jhund, Pardeep S., Docherty, Kieran F., Diez, Mirta, Petrie, Mark C., Verma, Subodh, Nicolau, Jose C., Merkely, Béla, Kitakaze, Masafumi, DeMets, David L., Inzucchi, Silvio E., Køber, Lars, Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Solomon, Scott D., Bengtsson, Olof, Lindholm, Daniel, Niklasson, Anna, Sjöstrand, Mikaela, Langkilde, Anna Maria, McMurray, John J.V.

Volltext

Reply: Beyond Remodeling: Interleukin-1 Blockade as a Therapeutic Strategy to Prevent Heart Failure After Myocardial Infarction von Carberry, Jaclyn, Docherty, Kieran F.

Volltext

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design von Carberry, Jaclyn, Petrie, Mark C., Lee, Matthew M.Y., Brooksbank, Katriona, Campbell, Ross T., Good, Richard, Jhund, Pardeep S., Kellman, Peter, Lang, Ninian N., Mangion, Kenneth, Mark, Patrick B., McConnachie, Alex, McMurray, John J.V., Meyer, Barbara, Orchard, Vanessa, Shaukat, Aadil, Watkins, Stuart, Welsh, Paul, Sattar, Naveed, Berry, Colin, Docherty, Kieran F.

Volltext

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF) von Lee, Matthew M.Y., Brooksbank, Katriona J.M., Wetherall, Kirsty, Mangion, Kenneth, Roditi, Giles, Campbell, Ross T., Berry, Colin, Chong, Victor, Coyle, Liz, Docherty, Kieran F., Dreisbach, John G., Labinjoh, Catherine, Lang, Ninian N., Lennie, Vera, McConnachie, Alex, Murphy, Clare L., Petrie, Colin J., Petrie, John R., Speirits, Iain A., Sourbron, Steven, Welsh, Paul, Woodward, Rosemary, Radjenovic, Aleksandra, Mark, Patrick B., McMurray, John J.V., Jhund, Pardeep S., Petrie, Mark C., Sattar, Naveed

Volltext

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes von Petrie, Mark C, Verma, Subodh, Docherty, Kieran F, Inzucchi, Silvio E, Anand, Inder, Belohlávek, Jan, Böhm, Michael, Chiang, Chern-En, Chopra, Vijay K, de Boer, Rudolf A, Desai, Akshay S, Diez, Mirta, Drozdz, Jaroslaw, Dukát, Andre, Ge, Junbo, Howlett, Jonathan, Katova, Tzvetana, Kitakaze, Masafumi, Ljungman, Charlotta E. A, Merkely, Béla, Nicolau, Jose C, O'Meara, Eileen, Vinh, Pham Nguyen, Schou, Morten, Tereshchenko, Sergey, Køber, Lars, Kosiborod, Mikhail N, Langkilde, Anna Maria, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Sjöstrand, Mikaela, Solomon, Scott D, Johanson, Per, Greasley, Peter J, Boulton, David, Bengtsson, Olof, Jhund, Pardeep S, McMurray, John J. V

Volltext

Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER von Jhund, Pardeep S., Kondo, Toru, Butt, Jawad H., Docherty, Kieran F., Claggett, Brian L., Desai, Akshay S., Vaduganathan, Muthiah, Gasparyan, Samvel B., Bengtsson, Olof, Lindholm, Daniel, Petersson, Magnus, Langkilde, Anna Maria, de Boer, Rudolf A., DeMets, David, Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Køber, Lars, Lam, Carolyn S. P., Martinez, Felipe A., Sabatine, Marc S., Shah, Sanjiv J., Solomon, Scott D., McMurray, John J. V.

Volltext

OUTSTEP‐HF: re‐evaluating the role of physical activity measures in drug and device development in heart failure von Docherty, Kieran F., Vaduganathan, Muthiah

Volltext

Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF von Docherty, Kieran F, Vaduganathan, Muthiah, Solomon, Scott D, McMurray, John J V

Volltext